Dr. Selvakumar Subbian is an Associate Professor Department of Medicine at the Public Health Research Institute, New Jersey Medical School at Rutgers University, Newark, NJ, USA. He received Doctoral degrees from the Department of Immunology, Tuberculosis Research Center (Indian Council of Medical Research), the Tamilnadu Dr. MGR Medical University in 2003. From 1996 to present, his area of research has been the pathogenesis of mycobacterial diseases in humans and host-directed therapy for tuberculosis. He and his team have recently established an immunocompetent and immunocompromised hamster model of pulmonary SARS-CoV-2 infection, and have been using the preclinical models for various translational studies. He has published over 100 peer-reviewed papers with an H-index of 35, as well as several book chapters and national/international conference/symposia presentations, since 2000. Dr. Subbian always welcomes productive research collaborations with scientists worldwide on tuberculosis and COVID-19 pathogenesis and intervention studies..
Dr. Selvakumar Subbian is an Associate Professor Department of Medicine at the Public Health Research Institute, New Jersey Medical School at Rutgers University, Newark, NJ, USA. He received Doctoral degrees from the Department of Immunology, Tuberculosis Research Center (Indian Council of Medical Research), the Tamilnadu Dr. MGR Medical University in 2003. From 1996 to present, his area of research has been the pathogenesis of mycobacterial diseases in humans and host-directed therapy for tuberculosis. He and his team have recently established an immunocompetent and immunocompromised hamster model of pulmonary SARS-CoV-2 infection, and have been using the preclinical models for various translational studies. He has published over 100 peer-reviewed papers with an H-index of 35, as well as several book chapters and national/international conference/symposia presentations, since 2000. Dr. Subbian always welcomes productive research collaborations with scientists worldwide on tuberculosis and COVID-19 pathogenesis and intervention studies..